Search Results - "Kuusalo, L"

Metabolic osteoarthritis – relation of diabetes and cardiovascular disease with knee osteoarthritis by Kuusalo, L., Felson, D.T., Wang, N., Lewis, C.E., Torner, J., Nevitt, M.C., Neogi, T.

“…There is an interest in identifying a metabolic OA phenotype. We therefore assessed the relation of diabetes and cardiovascular disease to prevalent and…”
Get full text

The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register by Backström, M, Salo, H, Kärki, J, Aalto, K, Rebane, K, Levälampi, T, Grönlund, M-M, Kröger, L, Pohjankoski, H, Hietanen, M, Korkatti, K, Kuusalo, L, Rantalaiho, V, Huhtakangas, J, Relas, H, Pääkkö, T, Löyttyniemi, E, Sokka-Isler, T, Vähäsalo, P

“…The ten-joint juvenile arthritis disease activity score (JADAS10) is designed to measure the level of disease activity in non-systemic juvenile idiopathic…”
Get full text

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial by Kuusalo, L, Puolakka, K, Kautiainen, H, Blåfield, H, Eklund, KK, Ilva, K, Kaipiainen-Seppänen, O, Karjalainen, A, Korpela, M, Valleala, H, Leirisalo-Repo, M, Rantalaiho, V, for the NEO-RACo Study Group

“…Objectives: It is well recognized that medication adherence of rheumatoid arthritis (RA) patients is often poor. As less attention has been paid to physicians'…”
Get full text

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort by Rannio, T, Asikainen, J, Hannonen, P, Yli-Kerttula, T, Ekman, P, Pirilä, L, Kuusalo, L, Mali, M, Puurtinen-Vilkki, M, Kortelainen, S, Paltta, J, Taimen, K, Kauppi, M, Laiho, K, Nyrhinen, S, Mäkinen, H, Isomäki, P, Uotila, T, Aaltonen, K, Kautiainen, H, Sokka, T

“…Objective: To assess what proportion of patients with disease-modifying anti-rheumatic drug (DMARD)-naïve early rheumatoid arthritis (ERA) reach 28-joint…”
Get full text

Comparing DAPSA, DAPSA28, and DAS28‐CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries by Linde, Louise, Georgiadis, Stylianos, Ørnbjerg, Lykke M., Rasmussen, Simon H., Michelsen, Brigitte, Askling, Johan, Di Giuseppe, Daniela, Wallman, Johan K., Závada, Jakub, Pavelka, Karel, Bernardes, Miguel, Matos, Carolina O., Glintborg, Bente, Loft, Anne Gitte, Nordström, Dan, Kuusalo, Laura, Möller, Burkhard, Nissen, Michael J., Codreanu, Catalin, Mogosan, Corina, Gudbjornsson, Bjorn, Love, Thorvardur Jon, Akleylek, Cansu, Iannone, Florenzo, Kvien, Tore K., Rotar, Ziga, Castrejon, Isabel, Macfarlane, Gary J., Hetland, Merete L., Østergaard, Mikkel

“…Objective Because 66/68 joint counts are not always performed in routine care, we aimed to determine which of the modified 28‐joint disease activity index for…”
Get full text

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice by Christiansen, Sara Nysom, Horskjær Rasmussen, Simon, Pons, Marion, Michelsen, Brigitte, Glintborg, Bente, Gudbjornsson, Bjorn, Grondal, Gerdur, Vencovsky, Jiri, Loft, Anne Gitte, Rotar, Ziga, Pirkmajer, Katja Perdan, Nissen, Michael J., Baranová, Jana, Macfarlane, Gary J., Jones, Gareth T., Iannone, Florenzo, Caporali, Roberto, Laas, Karin, Vorobjov, Sigrid, Giuseppe, Daniela Di, Olofsson, Tor, Provan, Sella Aarrestad, Fagerli, Karen Minde, Castrejon, Isabel, Otero-Varela, Lucia, van de Sande, Marleen, van der Horst-Bruinsma, Irene, Nordström, Dan, Kuusalo, Laura, Bernardes, Miguel, Hetland, Merete Lund, Østergaard, Mikkel, Midtbøll Ørnbjerg, Lykke

“…In patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA) initiating secukinumab, we aimed to assess and compare the proportion of patients…”
Get full text

Comparing Predictors of DAPSA28, DAPSA66/68 and DAS28-CRP Remission at 6 Months in Bio-naive Patients with Psoriatic Arthritis Initiating a TNFi in Clinical Practice - Results from the EuroSpA Collaboration by Georgiadis, S, Linde, L, Ornbjerg, L, Rasmussen, SH, Askling, J, Michelsen, B, Di Giuseppe, D, Wallman, JK, Glintborg, B, Loft, AG, Bernardes, M, Matos, CO, Nordstrom, D, Kuusalo, L, Moeller, B, Nissen, M, Gudbjornsson, B, Love, T, Iannone, F, Kvien, T, Rotar, Z, Castrejon, I, Macfarlane, G, van de Sande, M, Hetland, M, Ostergaard, M

Get full text

The Impact of Smoking Status on One Year Secukinumab Retention Rate in 1,684 Patients with PsA: Real-World Results from the EuroSpA Collaboration by Ahmadzay, ZF, Georgiadis, S, Pons, M, Hetland, M, Glintborg, B, Heberg, J, Christiansen, SN, Rasmussen, SH, Loft, AG, Castrejon, I, Otero-Valera, L, Zavada, J, Pavelka, K, Relas, H, Kuusalo, L, Moeller, B, Nissen, M, Rotar, Z, Pirkmajer, KP, Oliveira, DS, Cruz-Machado, AR, Michelsen, B, Kristianslund, E, Gudbjornsson, B, Grondal, GM, Laas, K, Hellamand, P, Sari, I, Di Giuseppe, D, Ostergaard, M, Ornbjerg, L

Get full text

Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration by Pons, M, Rasmussen, SH, Christiansen, SN, Michelsen, B, Glintborg, B, Gudbjornsson, B, Grondal, GM, Vencovsky, J, Loft, AG, Rotar, Z, Pirkmajer, KP, Nissen, M, Moeller, B, Macfarlane, G, Jones, GT, Iannone, F, Caporali, RF, Laas, K, Vorobjov, S, Di Giuseppe, D, Coskun, BN, Yagiz, B, Provan, S, Fagerli, K, Castrejon, I, Otero-Valera, L, van de Sande, M, Van der Horst-Bruinsma, I, Nordstrom, D, Kuusalo, L, Vieira-Sousa, E, Bernardes, M, Olofsson, T, Baranov, J, Hetland, M, Ostergaard, M, Ornbjerg, L

Get full text

Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial by Kuusalo, Laura A, Puolakka, Kari T, Kautiainen, Hannu, Alasaarela, Eeva M, Hannonen, Pekka J, Julkunen, Heikki A, Kaipiainen-Seppänen, Oili A, Korpela, Markku M, Möttönen, Timo T, Paimela, Leena H, Peltomaa, Ritva L, Yli-Kerttula, Timo K, Leirisalo-Repo, Marjatta, Rantalaiho, Vappu M

“…To study the effects of neglecting intra-articular glucocorticoid injections (IAGCIs) into swollen joints in early rheumatoid arthritis (RA). Ninety-nine…”
Get full text